Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4869227
- 104 Pages
- February 2022
- Medical Devices
The United States Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics players cover Pfizer, GSK, Eli Lilly, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Stimulants
Non-stimulants
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pediatric and Adolescents
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
GSK
Eli Lilly
Novartis
Johnson & Johnson
Mallinckrodt
Hisamitsu
UCB
Takeda
Purdue Pharma
Impax Laboratories
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2017-2028
2.1.2 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Segment by Type
2.2.1 Stimulants
2.2.2 Non-stimulants
2.3 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type
2.3.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Segment by Application
2.4.1 Pediatric and Adolescents
2.4.2 Adults
2.5 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application
2.5.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
3 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Player
3.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Players
3.1.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics by Regions
4.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics by Country (2017-2022)
7.2 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast
10.1.3 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast
10.1.4 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast
10.1.5 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast
10.2 Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.2.2 Canada Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.2.3 Mexico Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.2.4 Brazil Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3 APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3.2 Japan Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3.3 Korea Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3.4 Southeast Asia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3.5 India Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.3.6 Australia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.4 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.4.2 France Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.4.3 UK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.4.4 Italy Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.4.5 Russia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.5 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.5.2 South Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.5.3 Israel Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.5.4 Turkey Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.5.5 GCC Countries Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast
10.6 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Type (2023-2028)
10.7 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.1.3 Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.2.3 GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.3.3 Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.4.3 Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.5.3 Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Mallinckrodt
11.6.1 Mallinckrodt Company Information
11.6.2 Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.6.3 Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Mallinckrodt Main Business Overview
11.6.5 Mallinckrodt Latest Developments
11.7 Hisamitsu
11.7.1 Hisamitsu Company Information
11.7.2 Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.7.3 Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Hisamitsu Main Business Overview
11.7.5 Hisamitsu Latest Developments
11.8 UCB
11.8.1 UCB Company Information
11.8.2 UCB Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.8.3 UCB Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 UCB Main Business Overview
11.8.5 UCB Latest Developments
11.9 Takeda
11.9.1 Takeda Company Information
11.9.2 Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.9.3 Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Takeda Main Business Overview
11.9.5 Takeda Latest Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Information
11.10.2 Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.10.3 Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Purdue Pharma Main Business Overview
11.10.5 Purdue Pharma Latest Developments
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Information
11.11.2 Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
11.11.3 Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Impax Laboratories Main Business Overview
11.11.5 Impax Laboratories Latest Developments
12 Research Findings and Conclusion
Table 1. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Stimulants
Table 3. Major Players of Non-stimulants
Table 4. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players Head office and Products Offered
Table 13. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics
Table 43. Key Market Challenges & Risks of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics
Table 44. Key Industry Trends of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics
Table 45. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 52. Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 53. Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. GSK Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 57. GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 58. GSK Main Business
Table 59. GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. GSK Latest Developments
Table 61. Eli Lilly Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 62. Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 63. Eli Lilly Main Business
Table 64. Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Eli Lilly Latest Developments
Table 66. Novartis Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 67. Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novartis Latest Developments
Table 71. Johnson & Johnson Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 72. Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 73. Johnson & Johnson Main Business
Table 74. Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Johnson & Johnson Latest Developments
Table 76. Mallinckrodt Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 77. Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 78. Mallinckrodt Main Business
Table 79. Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Mallinckrodt Latest Developments
Table 81. Hisamitsu Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 82. Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 83. Hisamitsu Main Business
Table 84. Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Hisamitsu Latest Developments
Table 86. UCB Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 87. UCB Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 88. UCB Main Business
Table 89. UCB Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. UCB Latest Developments
Table 91. Takeda Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 92. Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 93. Takeda Main Business
Table 94. Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Takeda Latest Developments
Table 96. Purdue Pharma Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 97. Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 98. Purdue Pharma Main Business
Table 99. Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Purdue Pharma Latest Developments
Table 101. Impax Laboratories Details, Company Type, Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Area Served and Its Competitors
Table 102. Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Offered
Table 103. Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Impax Laboratories Main Business
Table 105. Impax Laboratories Latest Developments
List of Figures
Figure 1. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics in Pediatric and Adolescents
Figure 8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Pediatric and Adolescents (2017-2022) & ($ Millions)
Figure 9. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics in Adults
Figure 10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Adults (2017-2022) & ($ Millions)
Figure 11. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
